Literature DB >> 11356257

Ethanol exerts different effects on myelin basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase expression in differentiating CG-4 oligodendrocytes.

E Bichenkov1, J S Ellingson.   

Abstract

Evidence suggests that abnormal myelination is one factor contributing to the neuoropathology associated with fetal alcohol syndrome. We investigated the potential teratogenic effects of ethanol (EtOH) on myelin formation by determining its effects on the developmentally regulated increased expression of myelin basic protein (MBP) and 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP) in differentiating CG-4 oligodendrocytes (OLGs). By using CG-4 OLGs in vitro we identified processes altered by ethanol actions exerted directly on OLGs. During the first 8 days of development, EtOH decreased the expression of the major structural 18.5 and 14 kDa MBP isoforms by at least 40% at 4 days of development. EtOH concentrations between 25 and 75 mM inhibited MBP expression in a dose-dependent manner. Adding or withdrawing EtOH on specific days of differentiation reversibly modulated the expression of MBP, and the degree of inhibition was directly related to the length of ethanol exposure. As little as two consecutive days of EtOH exposure either early or late during development caused at least a 20% inhibition, however, no short critical time window of EtOH vulnerability for the inhibition was observed. The ethanol effect was selective for MBP expression, as EtOH did not alter the developmentally-regulated increased expression of CNP isozymes or enzyme activity. The results indicate that one factor contributing to the development of fetal alcohol syndrome may be defective myelination resulting from delayed and decreased MBP expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356257     DOI: 10.1016/s0165-3806(01)00142-0

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  9 in total

1.  Motor response programming and movement time in children with heavy prenatal alcohol exposure.

Authors:  Roger W Simmons; Jennifer D Thomas; Susan S Levy; Edward P Riley
Journal:  Alcohol       Date:  2010-07-03       Impact factor: 2.405

Review 2.  Role of astrocytic glutamate transporter in alcohol use disorder.

Authors:  Jennifer R Ayers-Ringler; Yun-Fang Jia; Yan-Yan Qiu; Doo-Sup Choi
Journal:  World J Psychiatry       Date:  2016-03-22

3.  A DTI-based tractography study of effects on brain structure associated with prenatal alcohol exposure in newborns.

Authors:  Paul A Taylor; Sandra W Jacobson; André van der Kouwe; Christopher D Molteno; Gang Chen; Pia Wintermark; Alkathafi Alhamud; Joseph L Jacobson; Ernesta M Meintjes
Journal:  Hum Brain Mapp       Date:  2014-09-03       Impact factor: 5.038

4.  White matter characteristics and cognition in prenatally opiate- and polysubstance-exposed children: a diffusion tensor imaging study.

Authors:  K B Walhovd; L T Westlye; V Moe; K Slinning; P Due-Tønnessen; A Bjørnerud; A van der Kouwe; A M Dale; A M Fjell
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-04       Impact factor: 3.825

5.  Diffusion tensor imaging of the cerebellum and eyeblink conditioning in fetal alcohol spectrum disorder.

Authors:  Bruce S Spottiswoode; Ernesta M Meintjes; Adam W Anderson; Christopher D Molteno; Mark E Stanton; Neil C Dodge; John C Gore; Bradley S Peterson; Joseph L Jacobson; Sandra W Jacobson
Journal:  Alcohol Clin Exp Res       Date:  2011-07-25       Impact factor: 3.455

6.  Biobehavioral markers of adverse effect in fetal alcohol spectrum disorders.

Authors:  Sandra W Jacobson; Joseph L Jacobson; Mark E Stanton; Ernesta M Meintjes; Christopher D Molteno
Journal:  Neuropsychol Rev       Date:  2011-05-04       Impact factor: 7.444

7.  Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function.

Authors:  Zaibo Li; Tiefei Dong; Chris Pröschel; Mark Noble
Journal:  PLoS Biol       Date:  2007-02       Impact factor: 8.029

8.  Adequacy of maternal iron status protects against behavioral, neuroanatomical, and growth deficits in fetal alcohol spectrum disorders.

Authors:  Echoleah S Rufer; Tuan D Tran; Megan M Attridge; Matthew E Andrzejewski; George R Flentke; Susan M Smith
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

Review 9.  Molecular Neuropathology of Astrocytes and Oligodendrocytes in Alcohol Use Disorders.

Authors:  José J Miguel-Hidalgo
Journal:  Front Mol Neurosci       Date:  2018-03-20       Impact factor: 5.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.